SYNCOMF.BO
Price:
$19.83
Market Cap:
$18.63B
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It also offers anemia tablet and syrup, lycopene, minerals and vitamins capsules, products for eradication of vaginal pathogens, capsules for the treatment of menopause, herbal uterine tonic, syrup for the treatment lactation insufficiency, cough suppressants, liver tonic, medicine for bu...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
Stock Exchange
BSE
Ticker
SYNCOMF.BO
According to Syncom Formulations (India) Limited’s latest financial reports and current stock price. The company's current PE Ratio is 46.12. This represents a change of 35.74% compared to the average of 33.98 of the last 4 quarters.
The mean historical PE Ratio of Syncom Formulations (India) Limited over the last ten years is 48.09. The current 46.12 PE Ratio has changed 9.49% with respect to the historical average. Over the past ten years (40 quarters), SYNCOMF.BO's PE Ratio was at its highest in in the March 2015 quarter at 91.70. The PE Ratio was at its lowest in in the December 2020 quarter at 15.58.
Average
48.09
Median
50.69
Minimum
21.93
Maximum
67.50
Discovering the peaks and valleys of Syncom Formulations (India) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 59.17%
Maximum Annual PE Ratio = 67.50
Minimum Annual Increase = -50.56%
Minimum Annual PE Ratio = 21.93
Year | PE Ratio | Change |
---|---|---|
2024 | 43.45 | 59.17% |
2023 | 27.30 | -18.36% |
2022 | 33.43 | 52.42% |
2021 | 21.93 | -50.56% |
2020 | 44.36 | -22.19% |
2019 | 57.02 | -15.53% |
2018 | 67.50 | 12.45% |
2017 | 60.03 | -1.69% |
2016 | 61.06 | -5.78% |
2015 | 64.81 | 33.32% |
The current PE Ratio of Syncom Formulations (India) Limited (SYNCOMF.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
34.72
5-year avg
34.09
10-year avg
48.09
Syncom Formulations (India) Limited’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syncom Formulations (India) Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Syncom Formulations (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Syncom Formulations (India) Limited's PE Ratio?
How is the PE Ratio calculated for Syncom Formulations (India) Limited (SYNCOMF.BO)?
What is the highest PE Ratio for Syncom Formulations (India) Limited (SYNCOMF.BO)?
What is the 3-year average PE Ratio for Syncom Formulations (India) Limited (SYNCOMF.BO)?
What is the 5-year average PE Ratio for Syncom Formulations (India) Limited (SYNCOMF.BO)?
How does the current PE Ratio for Syncom Formulations (India) Limited (SYNCOMF.BO) compare to its historical average?